<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37287969</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Cognitive impairment in long-COVID and its association with persistent dysregulation in inflammatory markers.</ArticleTitle><Pagination><StartPage>1174020</StartPage><MedlinePgn>1174020</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1174020</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1174020</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To analyze the potential impact of sociodemographic, clinical and biological factors on the long-term cognitive outcome of patients who survived moderate and severe forms of COVID-19.</AbstractText><AbstractText Label="METHODS">We assessed 710 adult participants (Mean age = 55 &#xb1; 14; 48.3% were female) 6 to 11 months after hospital discharge with a complete cognitive battery, as well as a psychiatric, clinical and laboratory evaluation. A large set of inferential statistical methods was used to predict potential variables associated with any long-term cognitive impairment, with a focus on a panel of 28 cytokines and other blood inflammatory and disease severity markers.</AbstractText><AbstractText Label="RESULTS">Concerning the subjective assessment of cognitive performance, 36.1% reported a slightly poorer overall cognitive performance, and 14.6% reported being severely impacted, compared to their pre-COVID-19 status. Multivariate analysis found sex, age, ethnicity, education, comorbidity, frailty and physical activity associated with general cognition. A bivariate analysis found that G-CSF, IFN-alfa2, IL13, IL15, IL1.RA, EL1.alfa, IL45, IL5, IL6, IL7, TNF-Beta, VEGF, Follow-up C-Reactive Protein, and Follow-up D-Dimer were significantly (p&lt;.05) associated with general cognition. However, a LASSO regression that included all follow-up variables, inflammatory markers and cytokines did not support these findings.</AbstractText><AbstractText Label="CONCLUSION">Though we identified several sociodemographic characteristics that might protect against cognitive impairment following SARS-CoV-2 infection, our data do not support a prominent role for clinical status (both during acute and long-stage of COVID-19) or inflammatory background (also during acute and long-stage of COVID-19) to explain the cognitive deficits that can follow COVID-19 infection.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Damiano, Rocca, Serafim, Loftis, Talib, Pan, Cunha-Neto, Kalil, de Castro, Seelaender, Guedes, Nagahashi Marie, de Souza, Nitrini, Miguel, Busatto, Forlenza and HCFMUSP COVID-19 Study Group.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Damiano</LastName><ForeName>Rodolfo Furlan</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>Departamento e Instituto de Psiquiatria, Hospital das Cl&#xed;nicas da Faculdade de Medicina da Universidade de S&#xe3;o Paulo (HCFMUSP), S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rocca</LastName><ForeName>Cristiana Castanho de Almeida</ForeName><Initials>CCA</Initials><AffiliationInfo><Affiliation>Departamento e Instituto de Psiquiatria, Hospital das Cl&#xed;nicas da Faculdade de Medicina da Universidade de S&#xe3;o Paulo (HCFMUSP), S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serafim</LastName><ForeName>Antonio de P&#xe1;dua</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Instituto de Psicologia, Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loftis</LastName><ForeName>Jennifer M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Research &amp; Development Service, VA Portland Health Care System, Portland, OR, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Psychiatry and Behavioral Neuroscience, Oregon Health and Science University, Portland, OR, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talib</LastName><ForeName>Leda Leme</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Departamento e Instituto de Psiquiatria, Hospital das Cl&#xed;nicas da Faculdade de Medicina da Universidade de S&#xe3;o Paulo (HCFMUSP), S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Pedro M&#xe1;rio</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Departamento de Psiquiatria, Universidade Federal de S&#xe3;o Paulo, S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cunha-Neto</LastName><ForeName>Edecio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Departamento de C&#xed;nica M&#xe9;dica, Universidade de S&#xe3;o Paulo FMUSP, S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Investigation in Immunology/National Institutes for Science and Technology (iii/INCT), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalil</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Departamento de C&#xed;nica M&#xe9;dica, Universidade de S&#xe3;o Paulo FMUSP, S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Investigation in Immunology/National Institutes for Science and Technology (iii/INCT), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Castro</LastName><ForeName>Gabriela Salim</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Cancer Metabolism Research Group, Department of Surgery and LIM 26, Hospital das Cl&#xed;nicas, University of S&#xe3;o Paulo, S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seelaender</LastName><ForeName>Marilia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cancer Metabolism Research Group, Department of Surgery and LIM 26, Hospital das Cl&#xed;nicas, University of S&#xe3;o Paulo, S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guedes</LastName><ForeName>Bruno F</ForeName><Initials>BF</Initials><AffiliationInfo><Affiliation>Departamento de Neurologia, Universidade de S&#xe3;o Paulo FMUSP, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagahashi Marie</LastName><ForeName>Suely K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Departamento de Neurologia, Universidade de S&#xe3;o Paulo FMUSP, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Souza</LastName><ForeName>Heraldo Possolo</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Departamento de Emerg&#xea;ncias M&#xe9;dicas, Universidade de S&#xe3;o Paulo FMUSP, S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nitrini</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Departamento de Neurologia, Universidade de S&#xe3;o Paulo FMUSP, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miguel</LastName><ForeName>Euripedes Constantino</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Departamento e Instituto de Psiquiatria, Hospital das Cl&#xed;nicas da Faculdade de Medicina da Universidade de S&#xe3;o Paulo (HCFMUSP), S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Busatto</LastName><ForeName>Geraldo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Departamento e Instituto de Psiquiatria, Hospital das Cl&#xed;nicas da Faculdade de Medicina da Universidade de S&#xe3;o Paulo (HCFMUSP), S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forlenza</LastName><ForeName>Orestes V</ForeName><Initials>OV</Initials><AffiliationInfo><Affiliation>Departamento e Instituto de Psiquiatria, Hospital das Cl&#xed;nicas da Faculdade de Medicina da Universidade de S&#xe3;o Paulo (HCFMUSP), S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>I01 BX002061</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS- CoV-2</Keyword><Keyword MajorTopicYN="N">cognition</Keyword><Keyword MajorTopicYN="N">cohort study (or longitudinal study)</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>8</Day><Hour>4</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37287969</ArticleId><ArticleId IdType="pmc">PMC10242059</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1174020</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. . Extrapulmonary manifestations of COVID-19. Nat Med (2020) 26:1017&#x2013;32. doi: 10.1038/s41591-020-0968-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry (2021) 8:416&#x2013;27. doi: 10.1016/S2215-0366(21)00084-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62&#x2008;354 COVID-19 cases in the USA. Lancet Psychiatry (2021) 8:130&#x2013;40. doi: 10.1016/S2215-0366(20)30462-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30462-4</ArticleId><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Brutto OH, Wu S, Mera RM, Costa AF, Recalde BY, Issa NP. Cognitive decline among individuals with history of mild symptomatic SARS-CoV-2 infection: a longitudinal prospective study nested to a population cohort. Eur J Neurol (2021) 28:3245&#x2013;53. doi: 10.1111/ene.14775</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14775</ArticleId><ArticleId IdType="pmc">PMC8014083</ArticleId><ArticleId IdType="pubmed">33576150</ArticleId></ArticleIdList></Reference><Reference><Citation>Duindam HB, Kessels RPC, Van Den Borst B, Pickkers P, Abdo WF. Long-term cognitive performance and its relation to anti-inflammatory therapy in a cohort of survivors of severe COVID-19. Brain Behav Immun Health (2022) 25:100513. doi: 10.1016/j.bbih.2022.100513</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2022.100513</ArticleId><ArticleId IdType="pmc">PMC9482799</ArticleId><ArticleId IdType="pubmed">36159208</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiano RF, Guedes BF, De Rocca CC, De P&#xe1;dua Serafim A, Castro LHM, Munhoz CD, et al. . Cognitive decline following acute viral infections: literature review and projections for post-COVID-19. Eur Arch Psychiatry Clin Neurosci (2021) 272(1):139&#x2013;154. doi:&#xa0;10.1007/s00406-021-01286-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-021-01286-4</ArticleId><ArticleId IdType="pmc">PMC8231753</ArticleId><ArticleId IdType="pubmed">34173049</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. . Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun (2022) 101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh J, Cho WH, Barcelon E, Kim KH, Hong J, Lee SJ. SARS-CoV-2 spike protein induces cognitive deficit and anxiety-like behavior in mouse via non-cell autonomous hippocampal neuronal death. Sci Rep (2022) 12:5496. doi: 10.1038/s41598-022-09410-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-09410-7</ArticleId><ArticleId IdType="pmc">PMC8970073</ArticleId><ArticleId IdType="pubmed">35361832</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiano RF, Caruso MJG, Cincoto AV, De Almeida Rocca CC, De P&#xe1;dua Serafim A, Bacchi P, et al. . Post-COVID-19 psychiatric and cognitive morbidity: preliminary findings from a Brazilian cohort study. Gen Hosp Psychiatry (2022) 75:38&#x2013;45. doi: 10.1016/j.genhosppsych.2022.01.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2022.01.002</ArticleId><ArticleId IdType="pmc">PMC8734055</ArticleId><ArticleId IdType="pubmed">35134702</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis (2022) 22:e102&#x2013;7. doi: 10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiano RF, Neto DB, Oliveira JVR, Magalh&#xe3;es Santos J, Alves JVR, Guedes BF, et al. . Association between chemosensory impairment with neuropsychiatric morbidity in post-acute COVID-19 syndrome: results from a multidisciplinary cohort study. Eur Arch Psychiatry Clin Neurosci (2022) 273(2):325&#x2013;333. doi:&#xa0;10.1007/s00406-022-01427-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-022-01427-3</ArticleId><ArticleId IdType="pmc">PMC9142732</ArticleId><ArticleId IdType="pubmed">35633395</ArticleId></ArticleIdList></Reference><Reference><Citation>Wulf Hanson S, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, Ballouz T, et al. . Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. Jama (2022) 328:1604&#x2013;15. doi: 10.1001/jama.2022.18931</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Abate G, Memo M, Uberti D. Impact of COVID-19 on alzheimer's disease risk: viewpoint for research action. Healthcare (Basel) (2020) 8(3):286. doi: 10.3390/healthcare8030286</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare8030286</ArticleId><ArticleId IdType="pmc">PMC7551579</ArticleId><ArticleId IdType="pubmed">32839380</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyra ESNM, Barros-Arag&#xe3;o FGQ, De Felice FG, Ferreira ST. Inflammation at the crossroads of COVID-19, cognitive deficits and depression. Neuropharmacology (2022) 209:109023. doi: 10.1016/j.neuropharm.2022.109023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2022.109023</ArticleId><ArticleId IdType="pmc">PMC8894741</ArticleId><ArticleId IdType="pubmed">35257690</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh-Manoux A, Dugravot A, Brunner E, Kumari M, Shipley M, Elbaz A, et al. . Interleukin-6 and c-reactive protein as predictors of cognitive decline in late midlife. Neurology (2014) 83:486&#x2013;93. doi: 10.1212/WNL.0000000000000665</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000665</ArticleId><ArticleId IdType="pmc">PMC4141998</ArticleId><ArticleId IdType="pubmed">24991031</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, et al. . Neuroinflammation in alzheimer's disease. Lancet Neurol (2015) 14:388&#x2013;405. doi: 10.1016/S1474-4422(15)70016-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(15)70016-5</ArticleId><ArticleId IdType="pmc">PMC5909703</ArticleId><ArticleId IdType="pubmed">25792098</ArticleId></ArticleIdList></Reference><Reference><Citation>Solinas A, Piras MR, Deplano A. Cognitive dysfunction and hepatitis c virus infection. World J Hepatol (2015) 7:922&#x2013;5. doi: 10.4254/wjh.v7.i7.922</Citation><ArticleIdList><ArticleId IdType="doi">10.4254/wjh.v7.i7.922</ArticleId><ArticleId IdType="pmc">PMC4419096</ArticleId><ArticleId IdType="pubmed">25954475</ArticleId></ArticleIdList></Reference><Reference><Citation>Alford K, Vera JH. Cognitive impairment in people living with HIV in the ART era: a review. Br Med Bull (2018) 127:55&#x2013;68. doi: 10.1093/bmb/ldy019</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bmb/ldy019</ArticleId><ArticleId IdType="pubmed">29868901</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin LH, Benning L, Keating SM, Norris PJ, Burke-Miller J, Savarese A, et al. . Variability in c-reactive protein is associated with cognitive impairment in women living with and without HIV: a longitudinal study. J Neurovirol (2018) 24:41&#x2013;51. doi: 10.1007/s13365-017-0590-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-017-0590-4</ArticleId><ArticleId IdType="pmc">PMC6036635</ArticleId><ArticleId IdType="pubmed">29063513</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstein AA, Estep JM, De Avila L, Curry M, Golabi P, Escheik C, et al. . Relationships among neurotransmitters, cytokines and cognitive performance for individuals with hepatitis c achieving sustained virologic response: a pilot study. J Neuroimmunol (2019) 335:577022. doi: 10.1016/j.jneuroim.2019.577022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2019.577022</ArticleId><ArticleId IdType="pubmed">31445380</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoare J, Myer L, Heany S, Fouche J-P, Phillips N, Zar HJ, et al. . Cognition, structural brain changes, and systemic inflammation in adolescents living with HIV on antiretroviral therapy. J acquired Immune deficiency syndromes (1999) (2020) 84:114&#x2013;21. doi: 10.1097/QAI.0000000000002314</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAI.0000000000002314</ArticleId><ArticleId IdType="pmc">PMC7141763</ArticleId><ArticleId IdType="pubmed">32032303</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein R, Soung A, Sissoko C, Nordvig A, Canoll P, Mariani M, et al. . COVID-19 induces neuroinflammation and loss of hippocampal neurogenesis. Res Sq. (2021) 29:rs.3.rs-1031824. doi: 10.21203/rs.3.rs-1031824/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1031824/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, De Lorenzo R, Magnaghi C, Poletti S, Furlan R, et al. . Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up. Brain Behavior Immun (2021) 94:138&#x2013;47. doi: 10.1016/j.bbi.2021.02.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.02.021</ArticleId><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Busatto GF, Araujo ALD, Mauricio Castaldelli-Maia J, Damiano RF, Imamura M, Guedes BF, et al. . Post-acute sequelae of SARS-CoV-2 infection: relationship of central nervous system manifestations with physical disability and systemic inflammation. psychol Med (2022) 52(12):2387&#x2013;2398. doi:&#xa0;10.1017/S0033291722001374</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291722001374</ArticleId><ArticleId IdType="pmc">PMC9151630</ArticleId><ArticleId IdType="pubmed">35521752</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Nicholson TR, Needham DM, Seylanova N, Parr C, Chen J, et al. . Studying the post-COVID-19 condition: research challenges, strategies, and importance of core outcome set development. BMC Med (2022) 20:50. doi: 10.1186/s12916-021-02222-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02222-y</ArticleId><ArticleId IdType="pmc">PMC8813480</ArticleId><ArticleId IdType="pubmed">35114994</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez M, Trent E, Goncalves BS, Pereira DG, Puri R, Frazier NA, et al. . Cognitive dysfunction associated with COVID-19: prognostic role of circulating biomarkers and microRNAs. Front Aging Neurosci (2022) 14:1020092. doi: 10.3389/fnagi.2022.1020092</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.1020092</ArticleId><ArticleId IdType="pmc">PMC9577202</ArticleId><ArticleId IdType="pubmed">36268187</ArticleId></ArticleIdList></Reference><Reference><Citation>Diana L, Regazzoni R, Sozzi M, Piconi S, Borghesi L, Lazzaroni E, et al. . Monitoring cognitive and psychological alterations in COVID-19 patients: a longitudinal neuropsychological study. J Neurol Sci (2022) 444:120511. doi: 10.1016/j.jns.2022.120511</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120511</ArticleId><ArticleId IdType="pmc">PMC9707027</ArticleId><ArticleId IdType="pubmed">36473347</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano-Castro PJ, Garz&#xf3;n-Maldonado FJ, Casado-Naranjo I, Ollero-Ortiz A, M&#xed;nguez-Castellanos A, Iglesias-Espinosa M, et al. . The cognitive and psychiatric subacute impairment in severe covid-19. Sci Rep (2022) 12:3563. doi: 10.1038/s41598-022-07559-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-07559-9</ArticleId><ArticleId IdType="pmc">PMC8894467</ArticleId><ArticleId IdType="pubmed">35241761</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Lu S, Chen J, Wei N, Wang D, Lyu H, et al. . The landscape of cognitive function in recovered COVID-19 patients. J Psychiatr Res (2020) 129:98&#x2013;1002. doi: 10.1016/j.jpsychires.2020.06.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2020.06.022</ArticleId><ArticleId IdType="pmc">PMC7324344</ArticleId><ArticleId IdType="pubmed">32912598</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, Mcauley H, Harrison EM, Shikotra A, Singapuri A, Sereno M, et al. . Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med (2021) 9:1275&#x2013;87. doi: 10.1016/S2213-2600(21)00383-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Biagianti B, Di Liberto A, Nicol&#xf2; Edoardo A, Lisi I, Nobilia L, De Ferrabonc GD, et al. . Cognitive assessment in SARS-CoV-2 patients: a systematic review. Front Aging Neurosci (2022) 14:909661. doi: 10.3389/fnagi.2022.909661</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.909661</ArticleId><ArticleId IdType="pmc">PMC9283975</ArticleId><ArticleId IdType="pubmed">35847679</ArticleId></ArticleIdList></Reference><Reference><Citation>Busatto Filho G, Araujo AL, Duarte AJS, Levin AS, Guedes BF, Kallas EG, et al. . Post-acute sequelae of sars-CoV-2 infection (PASC): protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalization in s&#xe3;o paulo, Brazil. BMJ Open (2021) 11(6):e051706. doi: 10.1136/bmjopen-2021-051706</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-051706</ArticleId><ArticleId IdType="pmc">PMC8249176</ArticleId><ArticleId IdType="pubmed">34193506</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet (2007) 370:1453&#x2013;7. doi: 10.1016/S0140-6736(07)61602-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)61602-X</ArticleId><ArticleId IdType="pubmed">18064739</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall JC, Murthy S, Diaz J, Adhikari NK, Angus DC, Arabi YM, et al. . A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis (2020) 20:e192&#x2013;7. doi: 10.1016/S1473-3099(20)30483-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30483-7</ArticleId><ArticleId IdType="pmc">PMC7292605</ArticleId><ArticleId IdType="pubmed">32539990</ArticleId></ArticleIdList></Reference><Reference><Citation>Roffman CE, Buchanan J, Allison GT. Charlson comorbidities index. J Physiother (2016) 62:171. doi: 10.1016/j.jphys.2016.05.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphys.2016.05.008</ArticleId><ArticleId IdType="pubmed">27298055</ArticleId></ArticleIdList></Reference><Reference><Citation>Lezak MD, Howieson DB, Loring DW, Hannay HJ, Fischer JS. Neuropsychological assessment. 4th ed. New York, NY, US: Oxford University Press; (2004).</Citation></Reference><Reference><Citation>Musoro JZ, Zwinderman AH, Puhan MA, Ter Riet G, Geskus RB. Validation of prediction models based on lasso regression with multiply imputed data. BMC Med Res Methodol (2014) 14:116. doi: 10.1186/1471-2288-14-116</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-116</ArticleId><ArticleId IdType="pmc">PMC4209042</ArticleId><ArticleId IdType="pubmed">25323009</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasquez MM, Hu C, Roe DJ, Chen Z, Halonen M, Guerra S. Least absolute shrinkage and selection operator type methods for the identification of serum biomarkers of overweight and obesity: simulation and application. BMC Med Res Methodol (2016) 16:154. doi: 10.1186/s12874-016-0254-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-016-0254-8</ArticleId><ArticleId IdType="pmc">PMC5109787</ArticleId><ArticleId IdType="pubmed">27842498</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y, Guo Z, Wang Y, Zhang H, Zhang F, Xu Z, et al. . Single-nucleus RNA sequencing reveals the shared mechanisms inducing cognitive impairment between COVID-19 and alzheimer's disease. Front Immunol (2022) 13:967356. doi: 10.3389/fimmu.2022.967356</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.967356</ArticleId><ArticleId IdType="pmc">PMC9538863</ArticleId><ArticleId IdType="pubmed">36211330</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurki SN, Kantonen J, Kaivola K, Hokkanen L, M&#xe4;yr&#xe4;np&#xe4;&#xe4; MI, Puttonen H, et al. . APOE &#x3f5;4 associates with increased risk of severe COVID-19, cerebral microhaemorrhages and post-COVID mental fatigue: a Finnish biobank, autopsy and clinical study. Acta Neuropathologica Commun (2021) 9:199. doi: 10.1186/s40478-021-01302-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-021-01302-7</ArticleId><ArticleId IdType="pmc">PMC8696243</ArticleId><ArticleId IdType="pubmed">34949230</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong N, Schiller MR, Li J, Chen X, Lin Z. Severe COVID-19 in alzheimer's disease: APOE4's fault again? Alzheimers Res Ther (2021) 13:111. doi: 10.1186/s13195-021-00858-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-021-00858-9</ArticleId><ArticleId IdType="pmc">PMC8197596</ArticleId><ArticleId IdType="pubmed">34118974</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderheiden A, Klein RS. Neuroinflammation and COVID-19. Curr Opin Neurobiol (2022) 76:102608. doi: 10.1016/j.conb.2022.102608</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2022.102608</ArticleId><ArticleId IdType="pmc">PMC9239981</ArticleId><ArticleId IdType="pubmed">35863101</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner JA, Padgett C, Mcdonald S, Ahuja KDK, Francis HM, Lim CK, et al. . Innate immunity impacts social-cognitive functioning in people with multiple sclerosis and healthy individuals: implications for IL-1ra and urinary immune markers. Brain Behav Immun Health (2021) 14:100254. doi: 10.1016/j.bbih.2021.100254</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100254</ArticleId><ArticleId IdType="pmc">PMC8474509</ArticleId><ArticleId IdType="pubmed">34589763</ArticleId></ArticleIdList></Reference><Reference><Citation>Strawbridge R, Carter R, Saldarini F, Tsapekos D, Young AH. Inflammatory biomarkers and cognitive functioning in individuals with euthymic bipolar disorder: exploratory study. BJPsych Open (2021) 7:e126. doi: 10.1192/bjo.2021.966</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjo.2021.966</ArticleId><ArticleId IdType="pmc">PMC8281256</ArticleId><ArticleId IdType="pubmed">36043690</ArticleId></ArticleIdList></Reference><Reference><Citation>He J, Russell T, Qiu X, Hao F, Kyle M, Chin L, et al. . The contribution of stem cell factor and granulocyte colony-stimulating factor in reducing neurodegeneration and promoting neurostructure network reorganization after traumatic brain injury. Brain Res (2020) 1746:147000. doi: 10.1016/j.brainres.2020.147000</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2020.147000</ArticleId><ArticleId IdType="pubmed">32579949</ArticleId></ArticleIdList></Reference><Reference><Citation>Loretelli C, Abdelsalam A, D&#x2019;addio F, Ben Nasr M, Assi E, Usuelli V, et al. . PD-1 blockade counteracts post&#x2013;COVID-19 immune abnormalities and stimulates the anti&#x2013;SARS-CoV-2 immune response. JCI Insight (2021) 6(24):e146701. doi: 10.1172/jci.insight.146701</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.146701</ArticleId><ArticleId IdType="pmc">PMC8783674</ArticleId><ArticleId IdType="pubmed">34784300</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahi V, Jamwal S, Kumar P. Neuroprotection through G-CSF: recent advances and future viewpoints. Pharmacol Rep (2021) 73:372&#x2013;85. doi: 10.1007/s43440-020-00201-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43440-020-00201-3</ArticleId><ArticleId IdType="pubmed">33389706</ArticleId></ArticleIdList></Reference><Reference><Citation>Langarizadeh MA, Ranjbar Tavakoli M, Abiri A, Ghasempour A, Rezaei M, Ameri A. A review on function and side effects of systemic corticosteroids used in high-grade COVID-19 to prevent cytokine storms. Excli J (2021) 20:339&#x2013;65. doi:&#xa0;10.17179/excli2020-3196</Citation><ArticleIdList><ArticleId IdType="doi">10.17179/excli2020-3196</ArticleId><ArticleId IdType="pmc">PMC7975631</ArticleId><ArticleId IdType="pubmed">33746666</ArticleId></ArticleIdList></Reference><Reference><Citation>C&#xe1;mara-Calmaestra R, Mart&#xed;nez-Amat A, Aibar-Almaz&#xe1;n A, Hita-Contreras F, De Miguel Hernando N, Achalandabaso-Ochoa A. Effectiveness of physical exercise on alzheimer's disease. a systematic review. J Prev Alzheimers Dis (2022) 9:601&#x2013;16. doi:&#xa0;10.14283/jpad.2022.57</Citation><ArticleIdList><ArticleId IdType="doi">10.14283/jpad.2022.57</ArticleId><ArticleId IdType="pubmed">36281664</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen CS, Simonsen AH, Siersma V, Beyer N, Frederiksen KS, Gottrup H, et al. . Patients with alzheimer's disease who carry the APOE &#x3f5;4 allele benefit more from physical exercise. Alzheimers Dement (N Y) (2019) 5:99&#x2013;106. doi: 10.1016/j.trci.2019.02.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trci.2019.02.007</ArticleId><ArticleId IdType="pmc">PMC6461575</ArticleId><ArticleId IdType="pubmed">31011620</ArticleId></ArticleIdList></Reference><Reference><Citation>Frederiksen KS, Gjerum L, Waldemar G, Hasselbalch SG. Effects of physical exercise on alzheimer's disease biomarkers: a systematic review of intervention studies. J Alzheimers Dis (2018) 61:359&#x2013;72. doi: 10.3233/JAD-170567</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-170567</ArticleId><ArticleId IdType="pubmed">29154278</ArticleId></ArticleIdList></Reference><Reference><Citation>Ihle A, Gouveia &#xc9; R, Gouveia BR, Zuber S, Kliegel M. Cognitive reserve attenuates the relation between gastrointestinal diseases and subsequent decline in executive functioning. Dement Geriatr Cognit Disord (2019) 48:215&#x2013;8. doi: 10.1159/000505617</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000505617</ArticleId><ArticleId IdType="pubmed">32007989</ArticleId></ArticleIdList></Reference><Reference><Citation>Contador I, Alzola P, Stern Y, De La Torre-Luque A, Bermejo-Pareja F, Fern&#xe1;ndez-Calvo B. Is cognitive reserve associated with the prevention of cognitive decline after stroke? a systematic review and meta-analysis. Ageing Res Rev (2022) 84:101814. doi: 10.1016/j.arr.2022.101814</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2022.101814</ArticleId><ArticleId IdType="pubmed">36473672</ArticleId></ArticleIdList></Reference><Reference><Citation>Costas-Carrera A, S&#xe1;nchez-Rodr&#xed;guez MM, Ca&#xf1;izares S, Ojeda A, Mart&#xed;n-Villalba I, Prim&#xe9;-Tous M, et al. . Neuropsychological functioning in post-ICU patients after severe COVID-19 infection: the role of cognitive reserve. Brain Behav Immun Health (2022) 21:100425. doi: 10.1016/j.bbih.2022.100425</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2022.100425</ArticleId><ArticleId IdType="pmc">PMC8818554</ArticleId><ArticleId IdType="pubmed">35156065</ArticleId></ArticleIdList></Reference><Reference><Citation>Devita M, Di Rosa E, Iannizzi P, Bianconi S, Contin SA, Tiriolo S, et al. . Risk and protective factors of psychological distress in patients who recovered from COVID-19: the role of cognitive reserve. Front Psychol (2022) 13:852218. doi: 10.3389/fpsyg.2022.852218</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2022.852218</ArticleId><ArticleId IdType="pmc">PMC9204198</ArticleId><ArticleId IdType="pubmed">35719579</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>